2025-05-20 12:00
FDA sets new COVID booster guidelines requiring trials for approvals for healthy adults
NEW YORK (Reuters) -The U.S. Food and Drug Administration plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65, effectively limiting their availability later this year to older adults and those at risk…

